NCT03927950View on ClinicalTrials.gov

Investigation of Genetic Predictors of the Response to Selective Serotonin Re-uptake Inhibitors (SSRI) Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Major Depression
Interventions
DRUG

escitalopram

escitalopram 10-20mg per day 12 weeks

DRUG

bupropion

bupropion 150-300mg per day 6 weeks

Trial Locations (1)

50417

Department of Psychiatry, University of Tartu, Tartu

All Listed Sponsors
lead

University of Tartu

OTHER

NCT03927950 - Investigation of Genetic Predictors of the Response to Selective Serotonin Re-uptake Inhibitors (SSRI) Treatment | Biotech Hunter | Biotech Hunter